跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DUPHALAC SYRUP - HSA Drug Approval Details
Approvals
/
HSA
/
DUPHALAC SYRUP
Approved
THERAPEUTIC
DUPHALAC SYRUP
ABBOTT BIOLOGICALS B V (NETHERLANDS)
🇸🇬 Health Sciences Authority
Approval Date
May 18, 1989
Approval ID
5921787b3ab6aefd
Company
ABBOTT BIOLOGICALS B V (NETHERLANDS)
Type
Therapeutic
Approval Details
Approval Id
5921787b3ab6aefd
Drug Name
DUPHALAC SYRUP
Product Name
DUPHALAC SYRUP
Approval Number
SIN02818P
Approval Date
1989-05-18
Registrant
ABBOTT LABORATORIES (SINGAPORE ) PRIVATE LIMITED
Licence Holder
ABBOTT LABORATORIES (SINGAPORE) PRIVATE LIMITED
Drug Type
Therapeutic
Forensic Classification
GENERAL SALE LIST
Dosage Form
SYRUP
Route Of Administration
ORAL
Atc Code
A06AD11
Atc Item Name
lactulose
Pharma Manufacturer Name
ABBOTT LABORATORIES (SINGAPORE ) PRIVATE LIMITED
Active Ingredients
LACTULOSE
67 g/100 ml
LACTULOSE
67 g/100 ml
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
May 18, 1989
Approval ID
5921787b3ab6aefd
Type
Therapeutic
Back to HSA Approvals